Literature DB >> 10208278

Reactive microglia in aging and dementia: an immunohistochemical study of postmortem human brain tissue.

M Overmyer1, S Helisalmi, H Soininen, M Laakso, P Riekkinen, I Alafuzoff.   

Abstract

Significantly increased up-regulation of HLA DR (major histocompatibility complex class II antigen) was seen using immunohistochemistry in postmortem brain tissue from demented patients with Alzheimer's disease (AD) (73 cases, 61 females/12 males, mean age 84 +/- 9 years) compared to controls (22 cases, 10 females/12 males, mean age 78 +/- 9 years). The counts of HLA DR-expressing activated microglia were significantly higher in female AD patients compared to males, significantly higher in AD patients with the age at death greater than 75 years compared to those dying younger and higher, although not statistically significantly, in AD patients with the apolipoprotein E (ApoE) epsilon4 allele compared to those patients not carrying this allele. In contrast to the situation in AD patients, in the control cases the HLA DR expression was higher in males compared to females. Furthermore, in the very old non-demented patients (age at death > 80 years), a decrease in the up-regulation of HLA DR expression was observed. A significant correlation between activated microglia and neurofibrillary tangles was seen in female AD patients compared to males, in AD cases without ApoE epsilon4 allele compared to those with this allele, in sporadic cases compared to familial and in cases with senile rather than presenile onset of the disease. Our results indicate that there is an age- and/or sex-related variability in up-regulation of HLA DR expression of microglia and that the linkage between this up-regulation and AD lesions is significantly influenced by the ApoE epsilon4 allele, gender of subjects, age at onset and familiality of the disease.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10208278     DOI: 10.1007/s004010051002

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  22 in total

Review 1.  Role of microglia in central nervous system infections.

Authors:  R Bryan Rock; Genya Gekker; Shuxian Hu; Wen S Sheng; Maxim Cheeran; James R Lokensgard; Phillip K Peterson
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

Review 2.  Amylin and its G-protein-coupled receptor: A probable pathological process and drug target for Alzheimer's disease.

Authors:  Wei Qiao Qiu
Journal:  Neuroscience       Date:  2017-05-19       Impact factor: 3.590

Review 3.  Pathways to Parkinsonism Redux: convergent pathobiological mechanisms in genetics of Parkinson's disease.

Authors:  Ravindran Kumaran; Mark R Cookson
Journal:  Hum Mol Genet       Date:  2015-06-22       Impact factor: 6.150

4.  Type-I-interferon signaling drives microglial dysfunction and senescence in human iPSC models of Down syndrome and Alzheimer's disease.

Authors:  Mengmeng Jin; Ranjie Xu; Le Wang; Mahabub Maraj Alam; Ziyuan Ma; Sining Zhu; Alessandra C Martini; Azadeh Jadali; Matteo Bernabucci; Ping Xie; Kelvin Y Kwan; Zhiping P Pang; Elizabeth Head; Ying Liu; Ronald P Hart; Peng Jiang
Journal:  Cell Stem Cell       Date:  2022-07-07       Impact factor: 25.269

5.  Inflammatory Pathways Are Impaired in Alzheimer Disease and Differentially Associated With Apolipoprotein E Status.

Authors:  Courtney M Kloske; Adam J Dugan; Erica M Weekman; Zachary Winder; Ela Patel; Peter T Nelson; David W Fardo; Donna M Wilcock
Journal:  J Neuropathol Exp Neurol       Date:  2021-10-26       Impact factor: 3.148

6.  Inflammation in Alzheimer's disease: relevance to pathogenesis and therapy.

Authors:  Elina Zotova; James Ar Nicoll; Raj Kalaria; Clive Holmes; Delphine Boche
Journal:  Alzheimers Res Ther       Date:  2010-01-22       Impact factor: 6.982

7.  Functional genomics of brain aging and Alzheimer's disease: focus on selective neuronal vulnerability.

Authors:  Xinkun Wang; Mary L Michaelis; Elias K Michaelis
Journal:  Curr Genomics       Date:  2010-12       Impact factor: 2.236

8.  The dopamine β-hydroxylase -1021C/T polymorphism is associated with the risk of Alzheimer's disease in the Epistasis Project.

Authors:  Onofre Combarros; Donald R Warden; Naomi Hammond; Mario Cortina-Borja; Olivia Belbin; Michael G Lehmann; Gordon K Wilcock; Kristelle Brown; Patrick G Kehoe; Rachel Barber; Eliecer Coto; Victoria Alvarez; Panos Deloukas; Rhian Gwilliam; Reinhard Heun; Heike Kölsch; Ignacio Mateo; Abderrahim Oulhaj; Alejandro Arias-Vásquez; Maaike Schuur; Yurii S Aulchenko; M Arfan Ikram; Monique M Breteler; Cornelia M van Duijn; Kevin Morgan; A David Smith; Donald J Lehmann
Journal:  BMC Med Genet       Date:  2010-11-11       Impact factor: 2.103

Review 9.  Who fans the flames of Alzheimer's disease brains? Misfolded tau on the crossroad of neurodegenerative and inflammatory pathways.

Authors:  Norbert Zilka; Zuzana Kazmerova; Santosh Jadhav; Peter Neradil; Aladar Madari; Dominika Obetkova; Ondrej Bugos; Michal Novak
Journal:  J Neuroinflammation       Date:  2012-03-07       Impact factor: 8.322

10.  Quantitating the subtleties of microglial morphology with fractal analysis.

Authors:  Audrey Karperien; Helmut Ahammer; Herbert F Jelinek
Journal:  Front Cell Neurosci       Date:  2013-01-30       Impact factor: 5.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.